Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
4.382
-0.018 (-0.42%)
Oct 30, 2025, 9:06 AM EDT - Market open
AVR Market Cap
AVR has a market cap or net worth of $178.88 million as of October 30, 2025. Its market cap has increased by 6.37% in one year.
Market Cap
178.88M
Enterprise Value
152.65M
1-Year Change
6.37%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $178.88M, an increase of 260.13%. That is a compound annual growth rate of 17.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 178.88M | -2.75% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | 16.71M | -59.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |